← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
NDA · New Drug Application · Sponsor: MACLEODS PHARMA · Approved 2010-08-30
Drug application
- FDA Application #
NDA022537- Application type
- New Drug Application
- Brand name
- LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
- Generic name
- Lamivudine, Nevirapine, And Stavudine
- Active ingredients
- LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MACLEODS PHARMA
- First approval
- 2010-08-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown